Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.180
+0.030 (1.40%)
At close: May 20, 2026, 4:00 PM EDT
2.180
0.00 (0.00%)
After-hours: May 20, 2026, 4:10 PM EDT
Grace Therapeutics Employees
Grace Therapeutics had 6 employees as of March 31, 2025. The number of employees increased by 2 or 50.00% compared to the previous year.
Employees
6
Change (1Y)
2
Growth (1Y)
50.00%
Revenue / Employee
n/a
Profits / Employee
-$996,500
Market Cap
33.73M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 6 | 2 | 50.00% |
| Mar 31, 2024 | 4 | -28 | -87.50% |
| Mar 31, 2020 | 32 | 4 | 14.29% |
| Mar 31, 2019 | 28 | 17 | 154.55% |
| Feb 29, 2016 | 11 | 4 | 57.14% |
| Feb 28, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Pluri | 142 |
| Aligos Therapeutics | 82 |
| Evaxion | 46 |
| NextCure | 40 |
| Boundless Bio | 28 |
| Actinium Pharmaceuticals | 25 |
| Veru Inc. | 20 |
| RenovoRx | 17 |
GRCE News
- 8 days ago - Largest borrow rate increases among liquid names - TheFly
- 26 days ago - Grace Therapeutics price target lowered to $4 from $11 at Craig-Hallum - TheFly
- 26 days ago - Grace Therapeutics price target lowered to $8 from $12 at TD Cowen - TheFly
- 27 days ago - Grace Therapeutics down 48% after receipt of CRL from FDA for GTx-104 - TheFly
- 27 days ago - Grace Therapeutics, Inc trading resumes - TheFly
- 27 days ago - US FDA declines to approve Grace Therapeutics' drug for a type of stroke - Reuters
- 27 days ago - Grace Therapeutics issued Complete Response Letter from FDA - TheFly
- 27 days ago - Grace Therapeutics Provides Regulatory Update on New Drug Application for GTx-104 - GlobeNewsWire